Zai Lab Story

Zai Lab Limited -- USA Stock  

USD 23.44  0.07  0.3%

Macroaxis does not monitor all media channels or aggregates social signals for Zai Lab. But even though we do not provide professional-grade financial sentiment analysis on Zai Lab Limited, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for Zai Lab. See also Zai Lab Hype Analysis, Zai Lab Correlation and Zai Lab Performance
Zai Lab Limited to present at the 36th Annual JP Morgan Healthcare Conference
Zai Lab is a Shanghai-based innovative biopharmaceutical company focused on bringing transformative medicines for cancer, autoimmune and infectious diseases to patients in China and around the world.

Read More...   

Story Momentum

This media report from globenewswire.com distributed on January 3, 2018 was a factor to the next trading day price decrease.The trading date delta against the next closing price was 1.12% . The trading date delta when the story was published against the current closing price is 7.38% .

Did you try this?

Run Idea Optimizer Now
   

Idea Optimizer

Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Hide  View All  NextLaunch Idea Optimizer

Cash Flow from Operations

Cash Flow from Operations Comparative Analysis
  Cash Flow from Operations 
      Zai Lab Comparables 
Zai Lab is currently under evaluation in cash flow from operations category among related companies. Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investor or analyst to check on the quality of a company earnings.